Skip to main content

Table 2 Characteristics of ESRD patients and control subjects

From: Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease

Dependent Independent

Controla

(n = 847)

ESRDb

(n = 847)

p-value

Male (%)

377 (44.6%)

430 (50.8%)

0.011*

Age (mean ± SD, year)

73.50 ± 7.21

71.84 ± 12.93

0.001*

Diabetes mellitus (%)

105 (12.5%)

372 (80.3%)

< 0.001*

Hypertension (%)

358 (42.7%)

222 (81.3%)

< 0.001*

BMIc (mean ± SD, kg/m2)

24.22 ± 3.37

24.66 ± 4.80

0.420

Blood biochemical value (mean ± SD)

 BUNd (mg/dl)

15.90 ± 3.89

73.88 ± 24.72

< 0.001*

 Creatinine (mg/dl)

0.83 ± 0.72

9.42 ± 2.78

< 0.001*

 Blood sugar PC (mg/dl)

102.48 ± 25.20

148.90 ± 75.40

< 0.001*

 Triglycerides (mg/dl)

103.62 ± 40.82

157.02 ± 98.75

< 0.001*

 Cholesterol (mg/dl)

185.05 ± 33.35

162.42 ± 45.16

< 0.001*

 Glomerular filtration rate (GFR) (mL/min/1.73 m2)

93.81 ± 23.76

5.73 ± 2.45

< 0.001*

  1. *p < 0.05
  2. a: Control: GFR > 60; b: Case: Hemodialysis patients, GFR < 15; c: Body Mass Index; d: Blood urea nitrogen